The proteasomal inhibition model of Parkinson's disease: “Boon or bust”?
- 21 July 2006
- journal article
- editorial
- Published by Wiley in Annals of Neurology
- Vol. 60 (2) , 158-161
- https://doi.org/10.1002/ana.20939
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neuronsAnnals of Neurology, 2006
- Reproducible nigral cell loss after systemic proteasomal inhibitor administration to ratsAnnals of Neurology, 2006
- Lack of nigrostriatal pathology in a rat model of proteasome inhibitionAnnals of Neurology, 2006
- Proteasome inhibition and Parkinson's disease modelingAnnals of Neurology, 2006
- Proteasome inhibitor-induced model of Parkinson's diseaseAnnals of Neurology, 2006
- Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeysAnnals of Neurology, 2006
- Design-based stereology in neuroscienceNeuroscience, 2005
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- Brain proteasomal function in sporadic Parkinson's disease and related disordersAnnals of Neurology, 2002
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998